- Home
- IMCC vs EVAX Comparison
IMCC vs EVAX Comparison
Compare IMCC & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- EVAX
- Stock Information
- Founded
- IMCC 1980
- EVAX 2008
- Country
- IMCC Israel
- EVAX Denmark
- Employees
- IMCC N/A
- EVAX N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMCC Health Care
- EVAX Health Care
- Exchange
- IMCC Nasdaq
- EVAX Nasdaq
- Market Cap
- IMCC 8.8M
- EVAX 8.7M
- IPO Year
- IMCC N/A
- EVAX 2021
- Fundamental
- Price
- IMCC $1.99
- EVAX $0.88
- Analyst Decision
- IMCC
- EVAX Strong Buy
- Analyst Count
- IMCC 0
- EVAX 2
- Target Price
- IMCC N/A
- EVAX $11.00
- AVG Volume (30 Days)
- IMCC 245.1K
- EVAX 77.4K
- Earning Date
- IMCC 11-14-2024
- EVAX 10-31-2024
- Dividend Yield
- IMCC N/A
- EVAX N/A
- EPS Growth
- IMCC N/A
- EVAX N/A
- EPS
- IMCC N/A
- EVAX N/A
- Revenue
- IMCC $38,042,859.00
- EVAX $3,295,000.00
- Revenue This Year
- IMCC $22.59
- EVAX $4,845.21
- Revenue Next Year
- IMCC $20.53
- EVAX $30.30
- P/E Ratio
- IMCC N/A
- EVAX N/A
- Revenue Growth
- IMCC N/A
- EVAX N/A
- 52 Week Low
- IMCC $1.13
- EVAX $0.87
- 52 Week High
- IMCC $8.10
- EVAX $13.61
- Technical
- Relative Strength Index (RSI)
- IMCC 40.31
- EVAX 19.35
- Support Level
- IMCC $2.01
- EVAX $1.08
- Resistance Level
- IMCC $2.65
- EVAX $1.20
- Average True Range (ATR)
- IMCC 0.38
- EVAX 0.18
- MACD
- IMCC -0.11
- EVAX -0.01
- Stochastic Oscillator
- IMCC 6.05
- EVAX 1.11
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.